Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition Science
Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor with no targeted therapeutic options and in which chemotherapy is only partially effective.
Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition – Science
Be the first to comment